trial summary · NCT07322133
Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)
Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension: A Pilot Trial
Trial record from the TrialBase DB dataset, status RECRUITING, condition Hypotension and Shock, sponsored by University of California, Davis. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This pilot randomized clinical trial compares dopamine and norepinephrine as first-line vasoactive therapies in term and late preterm neonates with pulmonary hypertension associated with hypoxemic respiratory failure and systemic hypotension. Systemic hypotension is a common and clinically significant complication of persistent pulmonary hypertension of the newborn (PPHN) and frequently requires vasopressor support to maintain adequate systemic perfusion. Dopamine is commonly used in this setting; however, prior animal experimental and clinical data suggest it may increase pulmonary vascular resistance, potentially worsening right ventricular afterload and hypoxemia. Norepinephrine may preferentially increase systemic vascular resistance with less effect on the pulmonary circulation. This study evaluates short-term hemodynamic and oxygenation responses following initiation of dopamine or norepinephrine.
Source record: https://clinicaltrials.gov/study/NCT07322133
Facts
| registry id | NCT07322133 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE4 |
| study type | INTERVENTIONAL |
| lead condition | Hypotension and Shock |
| sponsor | University of California, Davis |
| sponsor class | OTHER |
| enrollment | 30 |
| start date | 2026-10-30 |
| primary completion | 2027-06-30 |
| completion | 2027-06-30 |
| results posted | not reported |
Conditions
- Hypotension and Shock
- Pulmonary Hypertension of the Newborn (PPHN)
- Hypoxemic Respiratory Failure
Interventions
- Dopamine administration
- Norepinephrine
Countries
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.